Targeting Breast Cancer and Their Stem Cell Population Through AMPK Activation: Novel Insights

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 Feb 15

PMID 35159385

Authors

Bhawna Uprety

Heidi Abrahamse

Affiliations

Soon will be listed here.

Abstract

Despite some significant advancements, breast cancer has become the most prevalent cancer in the world. One of the main reasons for failure in treatment and metastasis has been attributed to the presence of cancer initiating cells-cancer stem cells. Consequently, research is now being focussed on targeting cancer cells along with their stem cell population. Non-oncology drugs are gaining increasing attention for their potent anticancer activities. Metformin, a drug commonly used to treat type 2 diabetes, is the best example in this regard. It exerts its therapeutic action by activating 5' adenosine monophosphate-activated protein kinase (AMPK). Activated AMPK subsequently phosphorylates and targets several cellular pathways involved in cell growth and proliferation and the maintenance of stem-like properties of cancer stem cells. Therefore, AMPK is emerging as a target of choice for developing effective anticancer drugs. Vanadium compounds are well-known PTP inhibitors and AMPK activators. They find extensive applications in treatment of diabetes and obesity via PTP1B inhibition and AMPK-mediated inhibition of adipogenesis. However, their role in targeting cancer stem cells has not been explored yet. This review is an attempt to establish the applications of insulin mimetic vanadium compounds for the treatment of breast cancer by AMPK activation and PTP1B inhibition pathways.

Citing Articles

The Common Hallmarks and Interconnected Pathways of Aging, Circadian Rhythms, and Cancer: Implications for Therapeutic Strategies.

Wang J, Shao F, Yu Q, Ye L, Wusiman D, Wu R Research (Wash D C). 2025; 8:0612.

PMID: 40046513 PMC: 11880593. DOI: 10.34133/research.0612.

CircWHSC1 (CircNSD2): A Novel Circular RNA in Multiple Cancers.

Zhang X, Yuan Y, Wang X, Wang H, Zhang L, He J Clin Med Insights Oncol. 2024; 18:11795549241254781.

PMID: 38855031 PMC: 11159554. DOI: 10.1177/11795549241254781.

Repurposing Therapeutic Drugs Complexed to Vanadium in Cancer.

De Sousa-Coelho A, Fraqueza G, Aureliano M Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38275998 PMC: 10819319. DOI: 10.3390/ph17010012.

The role of AMPK in macrophage metabolism, function and polarisation.

Cui Y, Chen J, Zhang Z, Shi H, Sun W, Yi Q J Transl Med. 2023; 21(1):892.

PMID: 38066566 PMC: 10709986. DOI: 10.1186/s12967-023-04772-6.

Targeting Breast Cancer: An Overlook on Current Strategies.

Iacopetta D, Ceramella J, Baldino N, Sinicropi M, Catalano A Int J Mol Sci. 2023; 24(4).

PMID: 36835056 PMC: 9959993. DOI: 10.3390/ijms24043643.

References

Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z . AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 2013; 17(1):113-24. PMC: 3545102. DOI: 10.1016/j.cmet.2012.12.001. View

Liberti M, Locasale J . The Warburg Effect: How Does it Benefit Cancer Cells?. Trends Biochem Sci. 2016; 41(3):211-218. PMC: 4783224. DOI: 10.1016/j.tibs.2015.12.001. View

Ito Y, Hsu M, Bettaieb A, Koike S, Mello A, Calvo-Rubio M . Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury. Metabolism. 2017; 76:56-69. PMC: 5690491. DOI: 10.1016/j.metabol.2017.07.009. View

Liao S, Li J, Yu L, Sun S . Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer. J Zhejiang Univ Sci B. 2017; 18(4):334-342. PMC: 5394098. DOI: 10.1631/jzus.B1600184. View

Luo J, Hou Y, Xie M, Ma W, Shi D, Jiang B . CYC31, A Natural Bromophenol PTP1B Inhibitor, Activates Insulin Signaling and Improves Long Chain-Fatty Acid Oxidation in C2C12 Myotubes. Mar Drugs. 2020; 18(5). PMC: 7281472. DOI: 10.3390/md18050267. View

Jiao J, Huang L, Ye F, Shi M, Cheng X, Wang X . Cyclin D1 affects epithelial-mesenchymal transition in epithelial ovarian cancer stem cell-like cells. Onco Targets Ther. 2013; 6:667-77. PMC: 3699300. DOI: 10.2147/OTT.S44177. View

Zhuang Y, Miskimins W . Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27Kip1 or p21Cip1. J Mol Signal. 2008; 3:18. PMC: 2613390. DOI: 10.1186/1750-2187-3-18. View

Liu L, Yang Z, Xu Y, Li J, Xu D, Zhang L . Inhibition of oxidative stress-elicited AKT activation facilitates PPARγ agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. PLoS One. 2013; 8(8):e73038. PMC: 3758331. DOI: 10.1371/journal.pone.0073038. View

Kostrzewa T, Przychodzen P, Gorska-Ponikowska M, Kuban-Jankowska A . Curcumin and Cinnamaldehyde as PTP1B Inhibitors With Antidiabetic and Anticancer Potential. Anticancer Res. 2019; 39(2):745-749. DOI: 10.21873/anticanres.13171. View

10.

Saraei P, Asadi I, Azam Kakar M, Moradi-Kor N . The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances. Cancer Manag Res. 2019; 11:3295-3313. PMC: 6497052. DOI: 10.2147/CMAR.S200059. View

11.

Zadra G, Batista J, Loda M . Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies. Mol Cancer Res. 2015; 13(7):1059-72. PMC: 4504770. DOI: 10.1158/1541-7786.MCR-15-0068. View

12.

Xia P, Xu X . PI3K/Akt/mTOR signaling pathway in cancer stem cells: from basic research to clinical application. Am J Cancer Res. 2015; 5(5):1602-9. PMC: 4497429. View

13.

Kostrzewa T, Wolosewicz K, Jamrozik M, Drzezdzon J, Sieminska J, Jacewicz D . Curcumin and Its New Derivatives: Correlation between Cytotoxicity against Breast Cancer Cell Lines, Degradation of PTP1B Phosphatase and ROS Generation. Int J Mol Sci. 2021; 22(19). PMC: 8508995. DOI: 10.3390/ijms221910368. View

14.

Young K, Biggins L, Sharpe H . Protein tyrosine phosphatases in cell adhesion. Biochem J. 2021; 478(5):1061-1083. PMC: 7959691. DOI: 10.1042/BCJ20200511. View

15.

Wang Y, Xu W, Yan Z, Zhao W, Mi J, Li J . Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways. J Exp Clin Cancer Res. 2018; 37(1):63. PMC: 5859411. DOI: 10.1186/s13046-018-0731-5. View

16.

Queiroz E, Puukila S, Eichler R, Sampaio S, Forsyth H, Lees S . Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells. PLoS One. 2014; 9(5):e98207. PMC: 4032293. DOI: 10.1371/journal.pone.0098207. View

17.

Dohmen M, Krieg S, Agalaridis G, Zhu X, Shehata S, Pfeiffenberger E . AMPK-dependent activation of the Cyclin Y/CDK16 complex controls autophagy. Nat Commun. 2020; 11(1):1032. PMC: 7042329. DOI: 10.1038/s41467-020-14812-0. View

18.

Smith D, Pickering R, Lewith G . A systematic review of vanadium oral supplements for glycaemic control in type 2 diabetes mellitus. QJM. 2008; 101(5):351-8. DOI: 10.1093/qjmed/hcn003. View

19.

Hung Nguyen P, Le T, Thuong P, Dao T, Ndinteh D, Mbafor J . Cytotoxic and PTP1B inhibitory activities from Erythrina abyssinica. Bioorg Med Chem Lett. 2009; 19(23):6745-9. DOI: 10.1016/j.bmcl.2009.09.108. View

20.

Krishnan N, Koveal D, Miller D, Xue B, Akshinthala S, Kragelj J . Targeting the disordered C terminus of PTP1B with an allosteric inhibitor. Nat Chem Biol. 2014; 10(7):558-66. PMC: 4062594. DOI: 10.1038/nchembio.1528. View